Mark Sabag

Mark Sabag was appointed Executive Vice President, International Markets Commercial, in 2021, leading all commercial activities in a region comprising 27 markets, including key Latin America countries, Russia and Eastern Europe, Israel, the Middle East, Africa, Asia-Pacific, China and Japan.

The International Markets commercial unit manages a high-quality portfolio of specialty medicines, generics and biopharmaceuticals, active pharmaceutical ingredients (API) and over-the-counter (OTC) products - with full end-to-end profit and loss (P&L) accountability.

Prior to that Mark served as Executive Vice President, Chief Human Resources Officer before his role was expanded to include Global Communications, Brand and ESG. Leading up to that he held several senior Human Resources positions for Teva’s International Group and Mergers and Acquisitions (M&As).

Before joining Teva in 2006, he held several senior global human resources roles at Intel Corporation.